[ Price : $8.95]
Researchers say that the number of drug company Web sites offering vouchers or coupons for free samples or discounted prescription...[ Price : $8.95]
FDA grants BioMarin Pharmaceutical an orphan drug designation for 3,4-diaminopyridine (3,4-DAP) amifampridine phosphate for treati...[ Price : $8.95]
FDA issues EMD Serono a refuse-to-file letter on an NDA for cladribine tablets, indicated for treating relapsing forms of multiple...[ Price : $8.95]
Transcept Pharmaceuticals and FDA agree to meet 1/20/09 to discuss a Complete Response Letter on an NDA for Intermezzo (zolpidem t...[ Price : $8.95]
ORC Guideline says its latest research shows that many consumers dont pay attention to mandated risk information in TV and print d...[ Price : $8.95]
CDER director Janet Woodcock says that FDA is working with doctors, pharmacists, and others to strike a balance between access to ...[ Price : $8.95]
The Chicago Tribune says that patient advocates and some doctors complain about prescription data mining practices.[ Price : $8.95]
FDA asks Theravance to submit additional data and analyses for use in evaluating the safety and efficacy of its telavancin for tre...